Search papers, labs, and topics across Lattice.
1
0
0
2
In Japanese breast cancer patients with normal bone density, the combination of denosumab and postoperative adjuvant endocrine therapy significantly prevented the decline in lumbar spine BMD, and the consideration of denosumab as part of a comprehensive strategy for preserving bone health in a broader range of patients is supported.
